Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma

Purpose: Systemic therapy has often been used for patients with advanced hepatocellular carcinoma (HCC). However, due to drug resistance, the use of cytotoxic chemotherapy in the treatment of patients with advanced HCC has typically demonstrated low response rates. Secretory clusterin (sCLU) is expr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Wang, Xin, Zou, Fang, Zhong, Jingtao, Yue, Longtao, Wang, Fuhai, Wei, Honglong, Yang, Guangsheng, Jin, Tao, Dong, Xiaofeng, Li, Jie, Xiu, Peng
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5929085/
https://ncbi.nlm.nih.gov/pubmed/29721050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.23849
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars